Company: IXHL
Filing Date: 2025-03-24
Form Type: S-3
Source: 0001013762-25-001587
Chunk: 21

Company: Incannex Healthcare Inc.
Filing Date: 2025-03-24
Form: S-3
Chunk 21
---
 Offering” consist of 650,000 shares of Common Stock purchased in the Private Placement by Boothbay Absolute Return Strategies,        
 LP (“BBARS”) and excludes (i) 314,508 shares of Common Stock underlying the Pre-Funded Warrants held by BBARS and (ii) 964,508                
 shares of Common Stock  (subject to the adjustment and alternative cashless exercise provisions of the Series A Warrants) underlying          
 the Series A Warrants held by BBARS, the exercise of which are subject to receipt of the Stockholder Approval and certain beneficial          
 ownership limitations. 24,402,095 shares of Common Stock issuable upon the exercise of the Series A Warrants held by BBARS are not registered 
 for resale in this prospectus because these shares are subject to Stockholder Approval.  BBARS is managed by Boothbay Fund Management,        
 LLC, a Delaware limited liability company (“Boothbay”). Boothbay, in its capacity as the investment manager of BBARS, has                     
 the power to vote and the power to direct the disposition of all securities held by the BBARS. Ari Glass is the Managing Member of Boothbay.  
 Each of BBARS, Boothbay and Mr. Glass disclaim beneficial ownership of these securities, except to the extent of any pecuniary interest       
 therein. The business address of BBARS 689 Fifth Avenue, 12th Floor, New York, NY, 10022.                                                     |

<div align='center'>11</div>

| (9) | The shares reported under “Beneficially Ownership Prior                                                                                       
 to this Offering” consist of (i) 1,300,000 shares of Common Stock purchased in the Private Placement by 3i, LP (“3i”)                         
 and excludes (i) 629,015 shares of Common Stock underlying the Pre-Funded Warrants held by 3i and (ii) 1,929,015 shares of Common Stock       
 (subject to the adjustment and alternative cashless exercise provisions of the Series A Warrants) underlying the Series A Warrants            
 held by 3i, the exercise of which are subject to receipt of the Stockholder Approval and certain beneficial ownership limitations. 48,804,164 
 shares of Common Stock issuable upon the exercise of the Series A Warrants held by 3i are not registered for resale in this prospectus        
 because these shares are subject to Stockholder Approval. 3i Management LLC is the general partner of 3i, and Maier Joshua Tarlow is